RECRUITING

BINGO: Bridging Knowledge, Increasing Awareness

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The U.S. population is becoming more diverse, but minority groups are still significantly underrepresented in cancer clinical trials. This disparity limits our understanding of how treatments work across different populations. Efforts like the 21st Century Cures Act aim to improve inclusion, but challenges persist due to historical mistrust and complex barriers in healthcare. To address these issues, Penn State Health is using a fun and educational approach called "BINGO" to engage the African American/Black community in Dauphin and surrounding counties. Led by the PSCI Diversity Navigator, these BINGO games will provide information about cancer and clinical trials in a relaxed setting. The goal is to build trust, increase awareness, and ultimately improve participation of underrepresented groups in clinical trials. Through this initiative, they hope to connect participants with needed healthcare services and gather feedback to tailor future trials to community needs. This approach aims to foster collaboration between minority communities and the healthcare system, ensuring that clinical trials reflect the diversity of the population they aim to serve.

Official Title

BINGO: Bridging Knowledge, Increasing Awareness - Empowering the Black Community Through Educational Gamification on Cancer Screenings and Clinical Trial Diversity

Quick Facts

Study Start:2024-10-28
Study Completion:2026-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06504407

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age: Adults aged 18 years and above.
  2. 2. Gender Identity: Individuals identifying as cisgender, transgender, or females.
  3. 3. Language Proficiency: Proficiency in English equivalent to middle school/high school level.
  4. 4. Registration: Completion of registration via the provided RedCap link prior to the Bingo session.
  5. 5. Consent: Willingness to provide written consent at the beginning of the Bingo session to participate in the research study.
  1. 1. Age: Individuals under the age of 18 years.
  2. 2. Gender Identity: Participants who do not identify as cisgender, transgender, or females.
  3. 3. Language Proficiency: Inability to understand English at a middle school/high school level.
  4. 4. Previous Participation: Individuals who have already participated in a previous Bingo game session for this study.
  5. 5. Medical or Cognitive Impairment: Participants unable to provide informed consent or actively participate due to medical or cognitive reasons.

Contacts and Locations

Study Contact

Monali Vasekar
CONTACT
7175318678
mvasekar@pennstatehealth.psu.edu
Xin Liu, Ph.D
CONTACT
7175313073
xliu2@pennstatehealth.psu.edu

Principal Investigator

Monali Vasekar, MD
PRINCIPAL_INVESTIGATOR
Penn State Cancer Institute

Study Locations (Sites)

Penn State Cancer Institute
Hershey, Pennsylvania, 17033
United States

Collaborators and Investigators

Sponsor: Milton S. Hershey Medical Center

  • Monali Vasekar, MD, PRINCIPAL_INVESTIGATOR, Penn State Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-28
Study Completion Date2026-06-01

Study Record Updates

Study Start Date2024-10-28
Study Completion Date2026-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer Education
  • Health Equity